Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV

No new safety concerns emerged in the 20-week extension of the phase 3 VERIFY study.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/hematocrit-phlebotomy-benefits-seen-rusfertide-pv-2025a1000y84?src=rss

Author :

Publish date : 2025-12-07 19:08:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV

Potential Game-Changing Impact on Mismatched Unrelated Blood Cell Transplantation

Alzheimer’s Benefits May Continue After Donanemab Treatment Ends, Data Suggest

Related Posts

Empagliflozin Benefits HF Patients With High Serum Magnesium

Woman hospitalised over dessert containing nuts at Bradford business

Inside the Clinics Weathering America’s ICE Raids

Income Struggles Linked to Altered Brain Growth in Infants

What’s Driving CV Deaths in RA: Inflammation or Antibodies?

Pulse Oximeter Failings for Darker-Skinned People Might Not Have a Simple Solution

Empagliflozin Benefits HF Patients With High Serum Magnesium

Woman hospitalised over dessert containing nuts at Bradford business

Inside the Clinics Weathering America’s ICE Raids

Income Struggles Linked to Altered Brain Growth in Infants

What’s Driving CV Deaths in RA: Inflammation or Antibodies?

Pulse Oximeter Failings for Darker-Skinned People Might Not Have a Simple Solution

U.S. Health Spending Topped $5 Trillion in 2024, CMS Says

CDC Just Downgraded Several Vaccines for Kids: Here Are the Risks

Categories

Archives